DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals (NYSE Amex: NAVB) today announced that Thomas Tulip, Executive Vice President and Chief Business Officer of Navidea, will participate with five other biopharmaceutical executives as an expert panelist in a workshop entitled, Molecular Diagnostics: A Sector of Increasing Importance on Wednesday, January 11, 2012 from 8:00 AM – 9:00 AM PT at the Biotech Showcase Conference in San Francisco. The workshop will explore the challenges and opportunities within the Molecular diagnostic sector.
